APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

Michael Hahne(University of Geneva), Takao Kataoka(University of Geneva), Michael Schröter(University of Geneva), Kay Hofmann(University of Geneva), Martin Irmler(University of Geneva), Jean-Luc Bodmer(University of Geneva), Pascal Schneider(University of Geneva), Tierry Bornand(University of Geneva), Nils Holler(University of Geneva), Lars E. French(University of Geneva), Bernard Sordat(University of Geneva), Donata Rimoldi(University of Geneva), Jürg Tschopp(University of Geneva)
The Journal of Experimental Medicine
September 21, 1998
Cited by 506Open Access
Full Text

Abstract

Members of the tumor necrosis factor (TNF) family induce pleiotropic biological responses, including cell growth, differentiation, and even death. Here we describe a novel member of the TNF family designated APRIL (for a proliferation-inducing ligand). Although transcripts of APRIL are of low abundance in normal tissues, high levels of mRNA are detected in transformed cell lines, and in human cancers of colon, thyroid, and lymphoid tissues in vivo. The addition of recombinant APRIL to various tumor cells stimulates their proliferation. Moreover, APRIL-transfected NIH-3T3 cells show an increased rate of tumor growth in nude mice compared with the parental cell line. These findings suggest that APRIL may be implicated in the regulation of tumor cell growth.


Related Papers

No related papers found

Powered by citation graph analysis